Recombinant Human GSK3B Protein，His

GSK3B (Glycogen Synthase Kinase 3 Beta) is a serine/threonine kinase that plays a pivotal role in various cellular processes, including glycogen metabolism, cell differentiation, and apoptosis. It is implicated in several diseases, particularly in cancer, diabetes, and neurodegenerative disorders like Alzheimer's disease. The enzyme exists in two isoforms, GSK3A and GSK3B, with GSK3B being the more extensively studied variant due to its significant regulatory functions in the Wnt signaling pathway and insulin signaling. Elevated GSK3B activity has been linked to the phosphorylation of β-catenin, which leads to its degradation and thus negatively regulates Wnt signaling, a pathway crucial for cell proliferation and survival. Furthermore, GSK3B is a target for therapeutic intervention, as inhibiting its activity could reverse some pathological conditions associated with its overactivity. As a result, the development and study of recombinant GSK3B protein have garnered attention in both basic research and drug discovery. Understanding the structural and functional properties of GSK3B through recombinant techniques can facilitate the identification of potential inhibitors, enhancing our ability to develop effective treatments for GSK3B-related diseases. Furthermore, the use of recombinant GSK3B protein allows researchers to explore its interactions with various substrates and inhibitors in vitro, thereby providing insights into its regulatory mechanisms and potential therapeutic targets. This research not only aids in elucidating the biological functions of GSK3B but also contributes to the broader understanding of its role in disease pathology.